Full Text View
Tabular View
No Study Results Posted
Related Studies
Therapeutic Approaches to HAART-Induced Lipodystrophy
This study is currently recruiting participants.
Verified June 2012 by University of Texas Southwestern Medical Center
Study NCT00461552   Information provided by University of Texas Southwestern Medical Center

First Received on April 16, 2007.   Last Updated on June 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Lipodystrophy
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Lipid Metabolism Disorders
Metabolic Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Metabolic
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Metreleptin (Leptin)
Sponsors listed in this trial
University of Texas Southwestern Medical Center
Amylin Pharmaceuticals, LLC.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services